CHEMOMAB THERAPEUTICS LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8324 USD | -0.90% |
|
-4.32% | +63.22% |
| 05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
| 04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Bio Therapeutic Drugs | -0.90% | -4.32% | +63.22% | -52.43% | - | 11.93M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- CMMB Stock
- Charts Chemomab Therapeutics Ltd.
- Comparison Chart
